InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $0.975 0.025 (2.50%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$36 Initial Director's Interest Notice 16 Sep 2022 8:25AM $0.052 $0.975 risen by 1,775%
$36 Brian Leedman appointed to the Board of OncoSil 15 Sep 2022 9:06AM $0.052 $0.975 risen by 1,775%
$36 Appendix 4G and Corporate Governance Statement 31 Aug 2022 9:31AM $0.060 $0.975 risen by 1,525%
$36 Appendix 4E Announcement 31 Aug 2022 8:38AM $0.060 $0.975 risen by 1,525%
$36 Appendix 4E and Annual Report 31 Aug 2022 8:37AM $0.060 $0.975 risen by 1,525%
$36 Investor Presentation 3 Aug 2022 1:57PM $0.061 $0.975 risen by 1,498.36%
$36 Investor Presentation Webinar Wednesday 3rd August 2022 1 Aug 2022 4:48PM $0.058 $0.975 risen by 1,581.03%
$36 Monthly Activities/Appendix 4C Cash Flow Report 29 Jul 2022 9:57AM $0.059 $0.975 risen by 1,552.54%
$36 Patient treated in Spain proceeds to successful resection 19 Jul 2022 8:50AM $0.058 $0.975 risen by 1,581.03%
$36 Bupa UK Approves Reimbursement for OncoSil in the UK 4 Jul 2022 8:46AM $0.040 $0.975 risen by 2,337.50%
$36 FY 2023 Strategic Update 30 Jun 2022 8:25AM $0.040 $0.975 risen by 2,337.50%
$36 OncoSil PanCO Clinical Trial Presented At ESMO World WCGIC 29 Jun 2022 9:03AM $0.040 $0.975 risen by 2,337.50%
$36 Application for quotation of securities - OSL 14 Jun 2022 5:04PM $0.048 $0.975 risen by 1,931.25%
$36 Cleansing Notice 14 Jun 2022 5:01PM $0.048 $0.975 risen by 1,931.25%
$36 Change of Director's Interest Notice - Otto Buttula 14 Jun 2022 4:21PM $0.048 $0.975 risen by 1,931.25%
$36 Change of Director's Interest Notice - Nigel Lange 14 Jun 2022 4:20PM $0.048 $0.975 risen by 1,931.25%
$36 Change of Director's Interest Notice - Martin Cross 14 Jun 2022 4:19PM $0.048 $0.975 risen by 1,931.25%
$36 Application for quotation of securities - OSL 10 Jun 2022 9:55AM $0.052 $0.975 risen by 1,775%
$36 Entitlement Offer Results and Shortfall Notification 9 Jun 2022 9:46AM $0.049 $0.975 risen by 1,889.80%
$36 Trading Halt 8 Jun 2022 9:06AM $0.049 $0.975 risen by 1,889.80%
$36 Letter To Ineligible Shareholders 10 May 2022 4:07PM $0.050 $0.975 risen by 1,850%
$36 OncoSil Entitlement Offer Booklet 10 May 2022 4:07PM $0.050 $0.975 risen by 1,850%
$36 Application for quotation of securities - OSL 9 May 2022 4:08PM $0.052 $0.975 risen by 1,775%
$36 Cleansing Notice 9 May 2022 4:06PM $0.052 $0.975 risen by 1,775%
$36 Clarification Of Non-Renouncable Entitlement Offer Details 2 May 2022 9:23AM $0.058 $0.975 risen by 1,581.03%

401 - 425 of 807 results

Page 17 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.